These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20965668)

  • 1. Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
    Hoshikawa S; Sano T; Yoshida T; Ito H; Oyama T; Fukuda T
    Pathol Res Pract; 2010 Dec; 206(12):816-20. PubMed ID: 20965668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
    Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
    Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
    Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
    Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
    Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
    Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
    Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Cao L; Sun PL; Yao M; Chen S; Gao H
    Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA, HPV L1 capsid protein and p16
    Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
    Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
    J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
    Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions].
    Song Y; Li Q; Li L; Chen W; Shen GH; Qiao YL; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):352-5. PubMed ID: 22883455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker.
    Hilfrich R; Hariri J
    Anal Quant Cytol Histol; 2008 Apr; 30(2):78-82. PubMed ID: 18561743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.